Condition: Malignancy · Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
In this study, Al18F-PSMA-BCH PET/CT will be performed in patients with prostate specific membrane antigen positive tumor, to evaluate the tumour detection efficacy of Al18F-PSMA-BCH PET/CT.
This description comes directly from the study's public registry record.
Xin Cheng, MD · 15120002998 · cxpumc@foxmail.com
Guozhu Hou, MD · 15611145656 · 15611145656@163.com
Always discuss trial participation with your own doctor first.
| National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing, Chaoyang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05761366